scholarly article | Q13442814 |
P2093 | author name string | Ying Wang | |
Xiaoyan Li | |||
Zhuwen Yi | |||
Yongzhen Li | |||
Yanran Wang | |||
Xiaochuan Wu | |||
Xiqiang Dang | |||
Qingnan He | |||
Lanjun Shuai | |||
P2860 | cites work | DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome | Q38110459 |
Molecular genetics of familial hematuric diseases | Q38138908 | ||
RAAS inhibition and the course of Alport syndrome | Q38781843 | ||
Familial hematuria: A review | Q39150317 | ||
Clinical utility gene card for: Alport syndrome - update 2014. | Q41789358 | ||
X-linked Alport syndrome in Hellenic families: phenotypic heterogeneity and mutations near interruptions of the collagen domain in COL4A5. | Q43457773 | ||
Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling | Q44053821 | ||
Symmetrical reduced retinal thickness in a patient with Alport syndrome | Q45173920 | ||
Alport syndrome: impact of digenic inheritance in patients management. | Q52809939 | ||
Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome | Q78526734 | ||
The value of clinical criteria in identifying patients with X-linked Alport syndrome | Q24595912 | ||
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome | Q26748817 | ||
X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study | Q28205352 | ||
Alport retinopathy results from "severe" COL4A5 mutations and predicts early renal failure | Q33571328 | ||
Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes? | Q33642689 | ||
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy | Q34029815 | ||
Renal pathology and ultrastructural findings in Alport's syndrome | Q34097243 | ||
Women and Alport syndrome | Q35571750 | ||
Advances in Alport syndrome diagnosis using next-generation sequencing | Q35603690 | ||
Novel X-linked glomerulopathy is associated with a COL4A5 missense mutation in a non-collagenous interruption | Q35642498 | ||
Glomerular basement membrane and related glomerular disease | Q36336238 | ||
Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndrome. | Q36810465 | ||
Familial hematuria | Q36958957 | ||
Inherited diseases of the glomerular basement membrane | Q37038419 | ||
Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis | Q37386211 | ||
The renal lesions of Alport syndrome | Q37496342 | ||
Basement membranes and human disease. | Q37598031 | ||
Alport syndrome--insights from basic and clinical research | Q38061008 | ||
Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. | Q38076686 | ||
P433 | issue | 9 | |
P921 | main subject | Alport syndrome | Q1331116 |
X-linked Alport syndrome | Q27677597 | ||
P304 | page(s) | 4657-4665 | |
P577 | publication date | 2018-09-01 | |
P1433 | published in | International Journal of Clinical and Experimental Pathology | Q6051341 |
P1476 | title | Novel deletion mutation in a Chinese family with X-linked alport syndrome | |
P478 | volume | 11 |
Search more.